NICE proposes five prostate MRI tools for NHS use while more evidence is gathered.

This remains draft guidance, not a final recommendation or proof of better patient outcomes. In a Science Media Centre response, urology professor Prabhakar Rajan says the evidence remains limited. He calls for tests of significant cancer detection, unnecessary biopsies, and performance across patient groups and NHS settings.

Watch the final guidance and evidence on the whole diagnostic process, with radiologists retaining clinical oversight. Better-looking scan results alone cannot establish that patients benefit.